Behavioral Changes as the Earliest Clinical Manifestation of Progressive Supranuclear Palsy
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background:The clinical and pathological heterogeneity of progressive supranuclear palsy (PSP) is well established. Even with a well-defined clinical phenotype and a thorough laboratory workup, PSP can be misdiagnosed, especially in its early stages. Case Report: A 52-year-old woman, who we initially diagnosed with a behavioral variant of frontotemporal dementia developed parkinsonian features, which then progressed to gait instability and gaze abnormality. Conclusions: We report herein a pathologically confirmed case of PSP presenting with behavioral changes including agitation and irritability, which eventually led to the cardinal symptoms of progressive supranuclear palsy.
Abstract
Background:The clinical and pathological heterogeneity of progressive supranuclear palsy (PSP) is well established. Even with a well-defined clinical phenotype and a thorough laboratory workup, PSP can be misdiagnosed, especially in its early stages. Case Report: A 52-year-old woman, who we initially diagnosed with a behavioral variant of frontotemporal dementia developed parkinsonian features, which then progressed to gait instability and gaze abnormality. Conclusions: We report herein a pathologically confirmed case of PSP presenting with behavioral changes including agitation and irritability, which eventually led to the cardinal symptoms of progressive supranuclear palsy.
참고문헌 (12)
- Litvan I, "Clinical research criteria for the diagnosis of progressive supranuclear palsy(Steele-Richardson-Olszewski syndrome):report of the NINDS-SPSP international workshop", Neurology, 47, pp.1~9 (1996)
- Pearce JM, "Progressive supranuclear palsy(Steele-Richardson-Olszewski syndrome):a short historical review", Neurologist, 13, pp.302~304 (2007)
- Kang Y, "A validity study on the Korean.Mini-mental state examination(K-MMSE)in dementia patients", J Korean Neurol Assoc, 15, pp.300~307 (1997)
- Choi SH, "Estimating the validity of the Korean version of expanded clinical dementia rating(CDR)scale", J Korean Neurol Assoc, 19, pp.585~591 (2001)
- Cummings JL, "The Neuropsychiatric inventory: assessing psychopathology in dementia patients", Neurology, 48, pp.S10~S16 (1997)
- Litvan I, "Neuropsychiatric aspects of progressive supranuclear palsy", Neurology, 47, pp.1184~1189 (1996)
- Grafman J, "Frontal lobe function in progressive supranuclear palsy", Arch Neurol, 47, pp.553~558 (1990)
- Trzepacz PT, "Progressive supranuclear palsy misdiagnosed as schizophrenia", J Nerv Ment Dis, 173, pp.377~378 (1985)
- Murphy MA, "Neurodegenerative disorders mimicking progressive supranuclear palsy:a report of three cases", J Clin Neurosci, 12, pp.941~945 (2005)
- Williams DR, "Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy:Richardson’s syndrome and PSP-parkinsonism", Brain, 128, pp.1247~1258 (2005)
- Josephs KA, "Clinicopathologic analysis of frontotemporal and corticobasal degenerations and PSP", Neurology, 66, pp.41~48 (2006)
- Wakabayashi K, "Pathological heterogeneity in progressive supranuclear palsy and corticobasal degeneration", Neuropathology, 24, pp.79~86 (2004)
